- Home
- BANL vs COEP Comparison
BANL vs COEP Comparison
Compare BANL & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- COEP
- Stock Information
- Founded
- BANL 2015
- COEP 2017
- Country
- BANL Malaysia
- COEP United States
- Employees
- BANL N/A
- COEP N/A
- Industry
- BANL Oil Refining/Marketing
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BANL Energy
- COEP Health Care
- Exchange
- BANL Nasdaq
- COEP Nasdaq
- Market Cap
- BANL 31.6M
- COEP 32.4M
- IPO Year
- BANL 2023
- COEP N/A
- Fundamental
- Price
- BANL $1.23
- COEP $12.45
- Analyst Decision
- BANL
- COEP
- Analyst Count
- BANL 0
- COEP 0
- Target Price
- BANL N/A
- COEP N/A
- AVG Volume (30 Days)
- BANL 28.2K
- COEP 111.8K
- Earning Date
- BANL 09-12-2024
- COEP 03-25-2025
- Dividend Yield
- BANL N/A
- COEP N/A
- EPS Growth
- BANL N/A
- COEP N/A
- EPS
- BANL N/A
- COEP N/A
- Revenue
- BANL $521,173,543.00
- COEP N/A
- Revenue This Year
- BANL N/A
- COEP N/A
- Revenue Next Year
- BANL N/A
- COEP N/A
- P/E Ratio
- BANL N/A
- COEP N/A
- Revenue Growth
- BANL 24.34
- COEP N/A
- 52 Week Low
- BANL $0.55
- COEP $2.31
- 52 Week High
- BANL $1.35
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- BANL 64.53
- COEP 63.21
- Support Level
- BANL $1.05
- COEP $8.65
- Resistance Level
- BANL $1.26
- COEP $12.95
- Average True Range (ATR)
- BANL 0.09
- COEP 1.64
- MACD
- BANL -0.00
- COEP -0.16
- Stochastic Oscillator
- BANL 85.48
- COEP 75.25
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.